[
  {
    "ts": "2026-01-17T09:10:08+00:00",
    "headline": "Will Legal Scrutiny and Oxford BioMedica Bid Reshape EQT's (EQT) Earnings and Investment Narrative?",
    "summary": "EQT is facing heightened attention after parents sued its subsidiaries over alleged health impacts from emissions and regulators cited the company for an “abandoned” shale well in Pennsylvania, while it also approaches a deadline on a potential cash offer for Oxford BioMedica. At the same time, EQT is preparing to report its latest quarterly earnings, with analysts closely watching how legal, regulatory and acquisition developments intersect with its operational performance. We’ll now...",
    "url": "https://finance.yahoo.com/news/legal-scrutiny-oxford-biomedica-bid-091008513.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "ea2dbfd3-072d-31b5-a03d-ca8ad03169d1",
      "content": {
        "id": "ea2dbfd3-072d-31b5-a03d-ca8ad03169d1",
        "contentType": "STORY",
        "title": "Will Legal Scrutiny and Oxford BioMedica Bid Reshape EQT's (EQT) Earnings and Investment Narrative?",
        "description": "",
        "summary": "EQT is facing heightened attention after parents sued its subsidiaries over alleged health impacts from emissions and regulators cited the company for an “abandoned” shale well in Pennsylvania, while it also approaches a deadline on a potential cash offer for Oxford BioMedica. At the same time, EQT is preparing to report its latest quarterly earnings, with analysts closely watching how legal, regulatory and acquisition developments intersect with its operational performance. We’ll now...",
        "pubDate": "2026-01-17T09:10:08Z",
        "displayTime": "2026-01-17T09:10:08Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/da713992716ec87035eff27f58858a3e",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aURC7pMZPipu9ycaWNQk3Q--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/da713992716ec87035eff27f58858a3e.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/S_rTPvHqfyCuyyoDoOJr0g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/da713992716ec87035eff27f58858a3e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/legal-scrutiny-oxford-biomedica-bid-091008513.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/legal-scrutiny-oxford-biomedica-bid-091008513.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "OXBDF"
            },
            {
              "symbol": "EQT"
            },
            {
              "symbol": "NG=F"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]